Stock listing
Pepgen Inc.
Selected listing: PEPG · NASDAQ · USD · US
Pepgen Inc. (NASDAQ:PEPG), Health Technology. Latest release Aug 6, 2026: PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights.
- Ticker
- NASDAQ:PEPG
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Pepgen Inc.
The company is focused on developing innovative therapies for genetic diseases. Pepgen aims to address unmet medical needs through its advanced research and development efforts.
Latest news from Pepgen Inc.
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 6, 2026
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
August 6, 2026
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
May 21, 2026
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 12, 2026
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
March 29, 2026
Events
Replays
PepGen Inc. (PEPG) Q4 2023 Earnings Call
Thu, Mar 06, 2025 · 04:30 PM ET
Watch